Search

Your search keyword '"Nijhuis, M."' showing total 100 results

Search Constraints

Start Over You searched for: Author "Nijhuis, M." Remove constraint Author: "Nijhuis, M." Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
100 results on '"Nijhuis, M."'

Search Results

1. Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C

4. In-depth Characterization of Vaccine Breakthrough Infections With SARS-CoV-2 Among Health Care Workers in a Dutch Academic Medical Center.

5. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids.

7. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids.

8. Shock and kill within the CNS: A promising HIV eradication approach?

10. Prolonged SARS-CoV-2 RNA shedding in a young man recovering from traumatic pneumothorax

11. Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study

12. Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study

13. Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART

14. Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART

15. Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART

16. Incorporating network uncertainties in voltage dip state estimation

17. Integrating direct and indirect load control for congestion management in LV networks

18. Incorporating network uncertainties in voltage dip state estimation

19. Integrating direct and indirect load control for congestion management in LV networks

20. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B

21. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B

22. Rapid rebound of a highly replication competent preexisting CXCR4-tropic HIV variant after allogeneic stem cell transplantation with CCR5D32 stem cells

23. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B

24. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B

25. Rapid rebound of a highly replication competent preexisting CXCR4-tropic HIV variant after allogeneic stem cell transplantation with CCR5D32 stem cells

26. Acid-based formula with synbiotics modifies gut microbiota in non-ige mediated cow's milk allergic infants

27. Amino acid-based formula including specific synbiotics modifies the gut microbiota and reduces clinical symptoms in non-IgE mediated cow's milk allergic infants

28. Gaussian mixture based probabilistic load flow For LV-network planning

29. Stochastic residential harmonic source modeling for grid impact studies

30. Analysis of reflectivity & predictability of electricity network tariff structures for household consumers

32. Valuation of measurement data for low voltage network expansion planning

33. Analysis of reflectivity & predictability of electricity network tariff structures for household consumers

34. Valuation of measurement data for low voltage network expansion planning

36. Stochastic residential harmonic source modeling for grid impact studies

37. Gaussian mixture based probabilistic load flow For LV-network planning

41. Bottom-up Markov Chain Monte Carlo approach for scenario based residential load modelling with publicly available data

43. Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients

45. Bottom-up Markov Chain Monte Carlo approach for scenario based residential load modelling with publicly available data

46. Complex T-Cell Receptor Repertoire Dynamics Underlie the CD8(+) T-Cell Response to HIV-1

50. Complex T-Cell Receptor Repertoire Dynamics Underlie the CD8(+) T-Cell Response to HIV-1

Catalog

Books, media, physical & digital resources